Clinical Trials Directory

Trials / Completed

CompletedNCT06667310

Effects of Neutrophil/Lymphocyte, Platelet/Lymphocyte, CRP/Albumin and Lactate on Mortality in Trauma Patients Admitted to Intensive Care

Evaluatıon Of The Effect Of Neutrophıl/Lymphocyte, Platelet/Lymphocyte, Crp/Albumın, Base Defıcıt And Lactate Levels On Mortalıty Durıng The Admıssıon Of Trauma Patıents To Intensıve Care

Status
Completed
Phase
Study type
Observational
Enrollment
150 (actual)
Sponsor
Harran University · Academic / Other
Sex
All
Age
1 Year – 95 Years
Healthy volunteers

Summary

Intensive care units are medical units where patients are closely monitored 24 hours a day due to critical health problems that threaten their lives and where rapid interventions are made when necessary. The clinical conditions of patients in these units can change rapidly. There are many studies in the literature indicating that inflammation indicators such as Neutrophil/Lymphocyte, Platelet/Lymphocyte and C-Reactive Protein/Albumin ratios and blood gas values such as Lactate and Base Deficit are simple, cheap and rapid biomarkers that can provide an early idea about the clinical course of patients.

Detailed description

Intensive care units are medical units where patients are closely monitored 24 hours a day due to critical health problems that threaten their lives and where rapid interventions are made when necessary. The clinical conditions of patients in these units can change rapidly. There are many studies in the literature indicating that inflammation indicators such as Neutrophil/Lymphocyte, Platelet/Lymphocyte and C-Reactive Protein/Albumin ratios and blood gas values such as Lactate and Base Deficit are simple, cheap and rapid biomarkers that can provide an early idea about the clinical course of patients. The researchers aimed to evaluate the relationship between Neutrophil/Lymphocyte, Platelet/Lymphocyte and C-Reactive Protein/Albumin ratios and biomarkers such as Lactate and Base Deficit with the clinical course and survival of trauma patients admitted to the ICU and to see the compatibility of our data with the existing literature.

Conditions

Timeline

Start date
2024-11-05
Primary completion
2025-01-10
Completion
2025-05-15
First posted
2024-10-31
Last updated
2025-05-15

Locations

1 site across 1 country: Turkey (Türkiye)

Source: ClinicalTrials.gov record NCT06667310. Inclusion in this directory is not an endorsement.